Recombinant Mouse Protein lifeguard 1 (Grina)

What detection methods are available for measuring Mouse GRINA in experimental samples?

Multiple analytical approaches can be employed for GRINA detection:

Antibody-based methods:

• Western Blotting (WB): Anti-GRINA antibodies like A11283 can detect the protein with expected band at 68 kDa

• ELISA: Sandwich ELISA kits are available with detection ranges of 31.2-2000 pg/mL and sensitivity of approximately 15.72 pg/mL

mRNA expression analysis:

• qRT-PCR using specific primers for GRINA/Lfg1/Nmdara1

Methodological considerations:

• For ELISA applications, sample types can include serum, plasma, tissue homogenates, and cell culture supernatants

• For optimal results in Western blotting, GRINA antibodies can be stored at 4°C for three months or at -20°C for up to one year

• Sandwich ELISA methodology involves pre-coating antibodies onto a 96-well plate, followed by sample addition, incubation with biotin-conjugated reagent, and detection using HRP-conjugated reagent

What are the key functions of GRINA in cellular physiology?

GRINA serves multiple important functions in cellular physiology:

Calcium homeostasis regulation:

• GRINA is predominantly located at the ER membrane where it suppresses ER calcium release via inositol-1,4,5-trisphosphate receptors

• It maintains cytosolic Ca²⁺ concentration at low levels (around 100 nM) compared to ER and Golgi apparatus (3-5 thousand fold higher)

Anti-apoptotic regulation:

• Functions as a potential apoptotic regulator

• Participates in suppressing intrinsic apoptosis pathways by regulating cytosolic Ca²⁺ concentration during ER stress

Neuronal function:

• Plays a crucial role in neuronal function and synaptic plasticity

• Was initially identified as part of an NMDA receptor-like complex formed by 4 subunits

Unfolded Protein Response (UPR):

• Involved in the endoplasmic reticulum stress response pathway

• Contributes to the post-ischemic unfolded protein response

How should recombinant Mouse GRINA protein be stored and handled for optimal stability?

For optimal stability and activity of recombinant Mouse GRINA protein:

Storage conditions:

• Store lyophilized protein at -20°C for long-term storage

• After reconstitution, store at 4°C for short-term use (up to a week) or aliquot and store at -20°C

• Avoid repeated freeze-thaw cycles to maintain protein integrity

Reconstitution procedure:

• Reconstitute lyophilized protein in sterile PBS

• For extended storage, addition of at least 0.1% carrier protein (such as BSA) is recommended

• Gentle mixing after reconstitution is advised, as the protein may appear as a film at the bottom of the vial

Handling considerations:

• For experimental applications, consider using carrier-free preparations when the presence of BSA could interfere with downstream applications

• For cell culture applications or as ELISA standards, protein with carrier is generally recommended

What are the mechanisms by which GRINA regulates calcium homeostasis and cell death pathways?

GRINA employs several sophisticated mechanisms to regulate calcium homeostasis and cell death:

Calcium regulation models:
Three models have been proposed to explain how TMBIM proteins like GRINA arbitrate Ca²⁺ levels:

• Channel formation: GRINA may form calcium channels that facilitate Ca²⁺ leakage

• Indirect regulation: GRINA may interact with and modulate existing Ca²⁺ channels

• pH-dependent regulation: GRINA may respond to pH changes by altering Ca²⁺ flux

Cell death pathway interactions:

• While FAIM2 (another TMBIM family member) potentiates the activation of caspase 8, GRINA deficiency leads to strong activation of caspase 9

• This suggests GRINA regulates the intrinsic (mitochondrial) apoptotic pathway, whereas FAIM2 regulates the extrinsic pathway

Synergistic effects:

• Studies with double-deficient mice (Grina⁻/⁻Faim2⁻/⁻) revealed the highest neurological deficits and largest infarct sizes after stroke

• This indicates complementary but distinct roles for these TMBIM proteins in neuroprotection

How does GRINA function in the context of cerebral ischemia and neuroprotection?

GRINA plays critical roles during cerebral ischemia and offers neuroprotective effects through several mechanisms:

Ischemic response:

• GRINA deficiency (Grina⁻/⁻) leads to increased infarct volumes similar to Faim2⁻/⁻ mice following transient middle cerebral artery occlusion (tMCAO)

• The combined absence of both GRINA and FAIM2 produces the most severe neurological deficits, suggesting complementary protective functions

Erythropoietin (EPO) regulation:

• EPO administration upregulates both Grina and Faim2 mRNA levels in wildtype mice

• EPO significantly decreases infarct sizes and abrogates neurological impairments in wildtype mice but not in GRINA-deficient mice

• This indicates GRINA is a critical mediator of EPO's neuroprotective effects

Unfolded Protein Response (UPR) interaction:

• Cerebral ischemia causes accumulation of misfolded proteins and disruption of calcium homeostasis, leading to ER stress

• GRINA influences the post-ischemic UPR, particularly through the IRE1α and PERK branches

• EPO treatment affects Grina mRNA levels after oxygen-glucose deprivation (OGD), suggesting a regulatory relationship

Experimental evidence table:

What nuclear functions have been identified for GRINA, and how might they be investigated?

Recent research has identified potential nuclear functions for GRINA that extend beyond its membrane-associated roles:

Nuclear localization and DNA-binding:

• The cytoplasmic N-terminal half of GRINA contains a potential DNA-binding sequence

• This region also contains cleavage target sites and probable PY-nuclear localization sequences

• Under specific conditions, this domain may be released from the rest of the protein and enter the nucleus

Potential nuclear functions:

• Participation in transcription regulation

• Involvement in alternative splicing processes

• Facilitation of mRNA export for specific gene subsets

• Likely involvement in genes related to lipid/sterol synthesis, ribosome biogenesis, and cell cycle progression

Investigative approaches:

• Subcellular fractionation followed by immunoblotting to detect GRINA fragments in nuclear fractions

• Chromatin immunoprecipitation (ChIP) to identify DNA binding sites

• RNA immunoprecipitation to detect RNA-protein interactions

• Proximity ligation assays to identify nuclear protein interaction partners

• Creation of domain-specific mutants to analyze which regions are required for nuclear localization

What methodological considerations should be addressed when using knockout models to study GRINA function?

When designing and interpreting experiments using GRINA knockout models, researchers should consider several important factors:

Model generation concerns:

• Complete vs. conditional knockouts: Consider whether complete GRINA deletion affects development, potentially confounding adult phenotypes

• Background strain effects: Genetic background can significantly influence phenotype expression in Grina⁻/⁻ mice

• Compensatory mechanisms: Other TMBIM family members may be upregulated in GRINA knockouts

Experimental design factors:

• Mortality rates: Some Grina⁻/⁻ mice died during or shortly after surgical procedures, suggesting increased vulnerability that must be accounted for in study design

• Exclusion criteria: Studies have reported excluding some Grina⁻/⁻ mice due to extensive weight loss, which may introduce selection bias

Analytical considerations:

• Caspase activation patterns: Grina⁻/⁻ mice show strong activation of caspase 9 (intrinsic pathway), contrasting with Faim2⁻/⁻ mice (caspase 8, extrinsic pathway)

• Cell-type specific effects: Effects of GRINA deficiency may vary across cell types and tissues

• UPR branch activation: Both the IRE1α and PERK branches of the UPR are differentially affected in Grina⁻/⁻ mice

Validation approaches:

• Reintroduction experiments: Overexpression of Grina in knockout neurons can confirm phenotype rescue

• Combined knockouts: Double-deficient models (Grina⁻/⁻Faim2⁻/⁻) provide insights into complementary or redundant functions

What protein-protein interaction studies have been conducted with GRINA, and how might recombinant GRINA facilitate further interactome analysis?

Investigating GRINA's protein-protein interactions provides critical insights into its function:

Current interaction data:

• GRINA's interactome suggests roles beyond calcium regulation

• Preliminary data indicates interactions with proteins involved in endosome-to-Golgi retrieval pathways

• The N-terminal Proline-rich domain may serve as a hub for protein interactions

Methodological approaches for interactome studies:

• Affinity purification coupled with mass spectrometry:

  • Using recombinant tagged GRINA as bait

  • Domain-specific constructs to identify domain-specific interactions

• Proximity labeling approaches:

  • BioID or APEX2 fusion proteins to identify proximal interactors in living cells

  • Allows detection of transient or weak interactions

• Yeast two-hybrid screening:

  • Using domain-specific constructs as bait

  • Helps identify direct protein-protein interactions

• Co-immunoprecipitation validation:

  • Using anti-GRINA antibodies like A11283

  • Confirming putative interactions identified by high-throughput methods

Applications of recombinant GRINA:

• Domain-specific recombinant fragments can determine which regions mediate specific interactions

• In vitro binding assays with purified proteins can establish direct interactions

• Surface plasmon resonance or isothermal titration calorimetry using recombinant GRINA can determine binding affinities and kinetics

How can contradictions in GRINA functional studies be resolved through improved experimental design?

Resolving inconsistencies in GRINA research requires careful consideration of:

Source of contradictions:

• Historical misidentification: GRINA was initially misidentified as a glutamate-binding subunit of NMDA receptors before being recognized as a TMBIM family member

• Observed vs. calculated molecular weight discrepancy: GRINA has a calculated MW of ~41 kDa but is observed at ~68 kDa, suggesting significant post-translational modifications that may affect function

Enhanced experimental approaches:

• Protein expression system selection:

  • Yeast expression systems (like Pichia pastoris) provide natural folding and post-translational modifications

  • These are superior to E. coli systems for studying functionally authentic GRINA

• Cell-type specific analysis:

  • Different cell types may utilize GRINA in different pathways

  • Primary neurons, astrocytes, and microglia should be separately analyzed

• Integration of multiple analytical techniques:

  • Combine protein-level (Western blot, immunoprecipitation) with mRNA-level analyses

  • Correlate with functional assays (calcium imaging, apoptosis assays)

• Context-dependent studies:

  • Analyze GRINA function under specific stressors (ER stress, calcium dysregulation)

  • Compare normal vs. pathological conditions

Methodological standardization:

• Standardized reporting of expression systems for recombinant proteins

• Consistent use of antibodies with validated specificity

• Clear distinction between observations in different model systems

• Integration of both gain-of-function and loss-of-function approaches